T cell subpopulations mediating inhibition of feline immunodeficiency virus replication in mucosally infected cats

Microbes and Infection

Volumn 6, Issue 3, 2004, Pages 265-271

  Shimojima, Masayuki ^a   Nishimura, Yorihiro ^b   Miyazawa, Takayuki ^c,d   Tohya, Yukinobu ^a   Akashi, Hiroomi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

CD4; CD8; Cellular immune response; ELISA; Enzyme linked immunosorbent assay; FCM; Feline immunodeficiency virus; FIV; Flow cytometry; Major histocompatibility complex; MHC; Mucosal infection; PBL; Peripheral blood lymphocyte

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAT; CAT DISEASE; CELL CULTURE; CELL PROLIFERATION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; FEMALE; GENE REPLICATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CAT DISEASES; CATS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; IMMUNODEFICIENCY VIRUS, FELINE; LENTIVIRUS INFECTIONS; LEUKOCYTES, MONONUCLEAR; MUCOUS MEMBRANE; PROVIRUSES; T-LYMPHOCYTE SUBSETS; VIRUS REPLICATION;

FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 1542298272     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micinf.2003.12.002     Document Type: Article

References (49)

1. Pedersen N.C., Ho E.W., Brown M.L., Yamamoto J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science. 235:1987;790-793.
2. Ackley C.D., Yamamoto J.K., Levy N., Pedersen N.C., Cooper M.D. Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:1990;5652-5655.
3. Yamamoto J.K., Sparger E., Ho E.W., Andersen P.R., O'Connor T.P., Mandell C.P., Lowenstine L., Munn R., Pedersen N.C. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49:1988;1246-1258.
4. Beatty J.A., Willett B.J., Gault E.A., Jarrett O. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J. Virol. 70:1996;6199-6206.
5. Burkhard M.J., Mathiason C.K., Bowdre T., Hoover E.A. Feline immunodeficiency virus Gag- and Envspecific immune responses after vaginal versus intravenous infection. AIDS Res. Hum. Retroviruses. 17:2001;1767-1778.
6. Flynn J.N., Dunham S., Mueller A., Cannon C., Jarrett O. Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection. Vet. Immunol. Immunopathol. 85:2002;159-170.
7. Li J., Brown W.C., Song W., Carpino M.R., Wolf A.M., Grant C.K., Elder J.H., Collisson E.W. Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytolytic T-lymphocytes from infected cats. Virus Res. 38:1995;93-109.
8. Song W., Collisson E.W., Billingsley P.M., Brown W.C. Induction of feline immunodeficiency virus specific cytolytic T-cell responses from experimentally infected cats. J. Virol. 66:1992;5409-5417.
9. Song W., Collisson E.W., Li J., Wolf A.M., Elder J.H., Grant C.K., Brown W.C. Feline immunodeficiency virus (FIV)-specific cytolytic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. Virology. 209:1995;390-399.
10. + antiviral response that correlates with reduction of cell-associated virus. J. Infect. Dis. 177:1998;18-25.
11. + cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8 β chain. J. Infect. Dis. 178:1998;968-977.
12. + T lymphocytes suppresses FIV replication. J. Virol. 74:2000;676-683.
13. Crawford P.C., Papadi G.P., Levy J.K., Benson N.A., Mergia A., Johnson C.M. Tissue dynamics of CD8 lymphocytes that suppress viral replication in cats infected neonatally with feline immunodeficiency virus. J. Infect. Dis. 184:2001;671-681.
14. + T lymphocytes. Immunology. 96:1999;220-229.
15. Gebhard D.H., Dow J.L., Childers T.A., Alvelo J.I., Tompkins M.B., Tompkins W.A.F. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 180:1999;1503-1513.
16. Hohdatsu T., Okubo M., Koyama H. Feline CD8 T cell non-cytolytic anti-feline immunodeficiency virus activity mediated by a soluble factor(s). J. Gen. Virol. 79:1998;2729-2735.
17. + T cell non-cytolytic anti-feline immunodeficiency virus (FIV) activity. Arch. Virol. 145:2000;2525-2538.
18. + antiviral activity in cats infected with feline immunodeficiency virus. J. Virol. 70:1996;2474-2480.
19. + cells in human immunodeficiency virus type I pathogenesis: cytolytic and noncytolytic inhibition of viral replication. Adv. Immunol. 66:1997;273-311.
20. Finerty S., Stokes C.R., Gruffydd-Jones T.J., Hillman T.J., Barr F.J., Harbour D.A. Targeted lymph node immunization can protect cats from a mucosal challenge with feline immunodeficiency virus. Vaccine. 20:2002;49-58.
21. Finerty S., Stokes C.R., Gruffydd-Jones T.J., Hillman T.J., Reeves N.A., Whiting C.V., Schaaper W.M.M., Dalsgaard K., Harbour D.A. Mucosal immunization with experimental feline immunodeficiency virus (FIV) vaccines induces both antibody and T cell responses but dose not protect against rectal FIV challenge. Vaccine. 18:2000;3254-3265.
22. Jordan H.L., Howard J.G., Bucci J.G., Butterworth J.L., English R., Kennedy-Stoskopf S., Tompkins M.B., Tompkins W.A. Horizontal transmission of feline immunodeficiency virus with semen from seropositive cats. J. Reprod. Immunol. 41:1998;341-357.
23. Kohmoto M., Ikeda Y., Sato E., Nishimura Y., Inoshima Y., Shimojima M., Tohya Y., Mikami T., Miyazawa T. Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses. Clin. Diagn. Lab. Immunol. 10:2003;185-188.
24. Matteucci D., Pistello M., Mazzetti P., Giannecchini S., Isola P., Merico A., Zaccaro L., Rizzuti A., Bendinelli M. AIDS vaccination studies using feline immunodeficiency virus as a model: immunisation with inactivated whole virus suppresses viraemia levels following intravaginal challenge with infected cells but not following intravenous challenge with cell-free virus. Vaccine. 18:2000;119-130.
25. Obert L.A., Hoover E.A. Early pathogenesis of transmucosal feline immunodeficiency virus infection. J. Virol. 76:2002;6311-6322.
26. - cells in cats infected with feline immunodeficiency virus. J. Gen. Virol. 79:1998;91-94.
27. + lymphocyte subset. Immunology. 78:1993;1-6.
28. Kohmoto M., Miyazawa T., Sato E., Uetsuka K., Nishimura Y., Ikeda Y., Inada G., Doi K., Mikami T. Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant. Arch. Virol. 143:1998;1839-1845.
29. Miyazawa T., Furuya T., Itagaki S., Tohya Y., Takahashi E., Mikami T. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus. Arch. Virol. 108:1989;131-135.
30. Kawaguchi Y., Miyazawa T., Tohya Y., Takahashi E., Mikami T. Quantification of feline immunodeficiency virus in a newly established feline T-lymphoblastoid cell line (MYA-1 cells). Arch. Virol. 111:1990;269-273.
31. Kohmoto M., Uetsuka K., Ikeda Y., Inoshima Y., Shimojima M., Sato E., Inada G., Toyosaki T., Miyazawa T., Doi K., Mikami T. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV Petaluma strain. J. Vet. Med. Sci. 60:1998;315-321.
32. Shimojima M., Pecoraro M.R., Maeda K., Tohya Y., Miyazawa T., Mikami T. Characterization of anti-feline CD8 monoclonal antibodies. Vet. Immunol. Immunopathol. 61:1998;17-23.
33. Shimojima M., Morikawa S., Maeda K., Tohya Y., Miyazawa T., Mikami T. Generation of monoclonal antibodies against a feline CD antigen (CD4) expressed by a recombinant baculovirus. J. Vet. Med. Sci. 59:1997;467-469.
34. Maki N., Miyazawa T., Fukasawa M., Hasegawa A., Hayami M., Miki K., Mikami T. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates. Arch. Virol. 123:1992;29-45.
35. Olmsted R.A., Barnes A.K., Yamamoto J.K., Hirsch V.M., Purcell R.H., Johnson P.R. Molecular cloning of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA. 86:1989;2448-2452.
36. Lehmann R., von Beust B., Niederer E., Condrau M.A., Fierz W., Aubert A., Ackley C.D., Cooper M.D., Tompkins M.B., Lutz H. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 35:1992;199-214.
37. + thymic lymphocytes express reduced levels of CD8β and increased interferon γ in cats perinatally infected with the JSY3 molecular clone of feline immunodeficiency virus. AIDS Res. Hum. Retroviruses. 16:2000;1559-1571.
38. Berg A.-L., Johannisson A., Johansson M., Hein A., Berg M., Dorries R. Peripheral and intracerebral T cell immune response in cats naturally infected with Borna disease virus. Vet. Immunol. Immunopathol. 68:1999;241-253.
39. + individuals. Blood. 92:1998;198-206.
40. + T cells. Eur. J. Immunol. 31:2001;3248-3254.
41. Straube F., Herrmann T. Differential modulation of CD8β by rat γδ and αβ T cells after activation. Immunology. 104:2001;252-258.
42. Shimojima M., Nishimura Y., Miyazawa T., Kato K., Nakamura K., Izumiya Y., Akashi H., Tohya Y. A feline CD2 homologue interacts with human red blood cells. Immunology. 105:2002;360-366.
43. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 234:1986;1563-1566.
44. + human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T lymphocytes derived from the peripheral blood cells of an HIV-1-infected individual. AIDS Res. Hum. Retroviruses. 9:1993;61-68.
45. + cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. Proc. Natl. Acad. Sci. USA. 89:1992;11204-11208.
46. Kundu S.K., Merigan T.C. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes. AIDS. 6:1992;643-649.
47. + cell depletion. Cell. 54:1988;561-575.
48. Furci L., Scarlatti G., Burastero S., Tambussi G., Colognesi C., Quillent C., Longhi R., Loverro P., Borgonovo B., Gaffi D., Carrow E., Malnati M., Lusso P., Siccardi A.G., Lazzarin A., Beretta A. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR5 allele. J. Exp. Med. 186:1997;455-460.
49. + T cell responses associated with control of viremia. Science. 278:1997;1447-1450.